Reproducibility of two four-point clinical severity scores for lateral canthal lines (crow's feet)

Dermatologic Surgery

Volumn 32, Issue 10, 2006, Pages 1256-1260

  Hund, Tobias ^a   Ascher, Benjamin ^b   Rzany, Berthold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Clinique Iena   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; FACIAL EXPRESSION; FEMALE; HUMAN; KAPPA STATISTICS; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; REST; SCORING SYSTEM; WRINKLE;

EID: 33750033869     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32286.x     Document Type: Article

References (24)

1. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
2. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol 2002;47:834-40.
3. Carruthers JD, Lowe NJ, Menter MA, et al. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003;112:1089-98.
4. Lowe NJ, Asher B, Heckman M, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 2005;31:257-62.
5. Honeck P, Weiss C, Sterry W, Rzany B. Reproducibility of a four-point clinical severity score for glabellar frown lines. Br J Dermatol 2003;149:306-10.
6. Blitzer A, Binder WJ, Brin MF. Management of facial wrinkles with botulinum toxin injections. In: Office-based surgery of the head and neck. Philadelphia: Lippincott-Raven, 1998:p. 251-4.
7. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:569-72.
8. Ascher B, Klap P, Marion MH, Chanteloub F. Botulinum toxin in the treatment of fronto-glabellar and periorbital wrinkles: an initial study. Ann Chir Plast Esthet 1995;40:67-76.
9. Day DJ, Littler CM, Swift RW, Gottlieb S. The wrinkle severity rating scale: a validation study. Am J Clin Dermatol 2004;5:49-52.
10. Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstr Surg 2001;108:1735-50.
11. Kim EJ, Reeck JB, Maas CS. A validated rating scale for hyperkinetic facial lines. Arch Facial Plast Surg 2004;6:253-6.
12. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971;76:378-81.
13. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measure 1960;20:37-46.
14. Cicchetti DV, Allison T. A new procedure for assessing reliability of scoring EEG sleep recordings. Am J EEG Technol 1971;11:101-9.
15. Altman DG. Some common problems in medical research. In: Practical statistics for medical research, 8th ed.. London/Weinheim/New York: Chapman & Hall, 1998:p. 403-9.
16. Bland JM, Altman DG. Validating scales and indexes. BMJ 2002;324:606-7.
17. Ellis DA, Tan AK. Cosmetic upper-facial rejuvenation with botulinum. J Otolaryngol 1997;26:92-6.
18. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994;94:94-9.
19. Frankel AS, Kamer FM. Chemical browlift. Arch Otolaryngol Head Neck Surg 1998;124:321-3.
20. Heckmann M, Schon-Hupka G. Quantification of the efficiacy of botulinum toxin type A by digital image analysis. J Am Acad Dermatol 2001;45:508-14.
21. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
22. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
23. Rzany B, Philipp A, Schäfer T. Validierung und reproduzierbarkeit von kriterien zu diagnose und schweregrad der psoriasis. Allergo J 1997;6:367-8.
24. Bamford J. Interobserver variation in the assessment of rosacea. Arch Dermatol 1998;134:508.